Follow the PureTech Health plc share price and the full directors' dealings record of the company, a publicly traded company based in United Kingdom. Shares are quoted on the UK market, under the authority of RNS (LSE). Market capitalisation: €286.3m. The latest transaction was disclosed on 19 August 2026 (Vesting). Among the most active insiders: Robert Lyne Sharon Barber-Lui John LaMattina Michele Holcomb. The full history is accessible without an account.
7
Insider Decl.
n/a
Thresholds
€205,815
2 ops.
Buy Volume
n/a
1 ops.
Sell Volume
50Σ signal
Buys €205,815n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Eric Elenko - President Charles Sherwood - Chief Operating Officer, General Counsel, and Corporate Secretary Michael Inbar - Chief Accounting Officer·Executives·
Eric Elenko - President Michael Inbar - Chief Accounting Officer Charles Sherwood - Chief Operating Officer, General Counsel and Corporate Secretary·Executives·
PureTech Health plc is a biopharmaceutical company focused on discovering and developing new therapies for serious diseases. It employs an innovative approach to identify and commercialize therapeutic products.